Epoetin


Indications and Reactions:

Role Indications Reactions
Primary
Anaemia 100.0%
Thrombosis 100.0%
Secondary
Product Used For Unknown Indication 35.7%
Hepatic Cirrhosis 21.4%
Antiviral Treatment 10.7%
Peritoneal Dialysis 7.1%
Anaemia 3.6%
Immunosuppression 3.6%
Multiple Myeloma 3.6%
Prophylaxis 3.6%
Cardiac Failure 1.8%
Fluid Retention 1.8%
Muscle Spasms 1.8%
Renal Cell Carcinoma 1.8%
Renal Failure Chronic 1.8%
Sepsis 1.8%
Sepsis 25.0%
Platelet Count Decreased 12.5%
Thrombocythaemia 12.5%
Confusional State 6.3%
Encephalopathy 6.3%
Hepatic Enzyme Abnormal 6.3%
Hepatocellular Carcinoma 6.3%
Infection 6.3%
Product Quality Issue 6.3%
Pulmonary Embolism 6.3%
Thrombosis 6.3%
Concomitant
Product Used For Unknown Indication 34.4%
Drug Use For Unknown Indication 15.7%
Multiple Myeloma 11.1%
Hepatitis C 5.5%
Anaemia 4.0%
Diabetes Mellitus 3.0%
Renal Transplant 2.9%
Fistulogram 2.6%
Hypertension 2.6%
Arthritis Bacterial 2.2%
Nuclear Magnetic Resonance Imaging 2.1%
Atrial Fibrillation 1.8%
Prophylaxis 1.8%
Renal Failure Chronic 1.7%
Depression 1.6%
Diffuse Large B-cell Lymphoma 1.6%
Pain 1.6%
Infection 1.5%
Hyperparathyroidism Secondary 1.3%
Type 2 Diabetes Mellitus 1.0%
Death 13.9%
Pancytopenia 7.9%
Rhabdomyolysis 6.9%
Sepsis 6.9%
Skin Tightness 6.9%
Pneumonia 5.9%
Pyrexia 5.9%
Platelet Count Decreased 5.0%
Renal Osteodystrophy 5.0%
Drug Interaction 4.0%
Osteonecrosis 4.0%
Upper Airway Obstruction 4.0%
Chest Pain 3.0%
Diarrhoea 3.0%
Fatigue 3.0%
Gastrointestinal Haemorrhage 3.0%
Neutropenia 3.0%
Paraparesis 3.0%
Polyomavirus-associated Nephropathy 3.0%
Renal Failure 3.0%

Drug Data